4SheuJR, KanYC, HungWC, et al. The antiplatelet activity otet ramethylpyrazine is mediated through activation of NO syn thase[J]. Life Sci,2000,67(8) :937-938.
1Jiang F, Qian J, Chen S, et al. Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress [J]. Pharm Biol, 2011, 49(8) :856-863.
2Kuttler B, Steveling A, Klting N, et al. Aminoguanidine downregulates expression of cytokine-induced Fas and in- ducible nitric oxide synthase but not cytokine-enhanced surface antigens of rat islet cells Jl- Biochem Pharmacol, 2003, 66(12) :2437-2448.
3Raj DS, Choudhury D, Welbourne TC, et al. Advanced glycation end products : a Nephrologist's perspective [ J ]. Am J Kidney Dis, 2000, 35 (3) :365-380.
4Yang QH, Liang Y, Xu Q, et al. Protective effect of tet- ramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes [J] Phytomedicine, 2011, 18(13) :1148-1152.
5Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection- how, why, when, and where? [J]. Nitric Oxide, 1997, 1 (2) :107-120.
6Di Naso FC, Rodrigues G, Sim6es Dias A, et al. Hepatic nitrosative stress in experimental diabetes [ J]. J Diabetes Complications, 2012, 26 ( 5 ) : 378-381.
7Liu HT, Du YG, He JL, et al. Tetramethylpyrazine inhib- its production of nitric oxide and inducible nitric oxide syn- thase in lipopolysaccharide-induced N9 microglial cells through blockade of MAPK and PI3K/Akt signaling path- ways, and suppression of intracellular reactive oxygen spe- cies [ J ]. J Ethnopharmacol, 2010, 129 ( 3 ) :335-343.
